Biological response modifiers in rheumatoid arthritis

Lancet. 2002 Jan 26;359(9303):352. doi: 10.1016/s0140-6736(02)07508-6.
No abstract available

Publication types

  • Kommentar
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Arthritis, Rheumatoid / drug therapy*
  • Etanercept
  • Humans
  • Immunoglobulin G / administration & dosage*
  • Immunologic Factors / administration & dosage*
  • Infliximab
  • Infusions, Intravenous
  • Injections, Subcutaneous
  • Receptors, Tumor Necrosis Factor / administration & dosage*
  • Self Administration
  • Treatment Outcome
  • Vereinigte Staaten

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Immunologic Factors
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Etanercept